Mucocutaneous diseases in drug addicts with or without HIV infection. A case-control study.
A case-control study was performed to evaluate the prevalence of mucocutaneous diseases in 106 male drug addicts (age 21-38 years) with or without HIV infection. A mucocutaneous disease was recorded in ten out of 64 HIV-negative and in 20 of 42 HIV-positive patients (OR = 4.9; p < 0.01). Some mucocutaneous diseases were present in similar proportions in both groups (i.e. fungal skin lesions), while others were typically present only in HIV-positive patients. Stratification for possible confounding factors, such as years of drug addiction and number of sexual partners, confirmed that HIV infection is the main risk factor for mucocutaneous disease. Stratification according to the number of CD4-positive cells showed that the more advanced the HIV disease, the more frequently mucocutaneous disease was present (p = 0.02). The study demonstrates that many, but not all, mucocutaneous diseases are associated with HIV infection.
Gaeta
G B
GB
Clinica Malattie Infettive, Seconda Universita, Naples, Italy.
Maisto
A
A
Sichenze
C
C
Satriano
R A
RA
Sardaro
C
C
Giusti
G
G
D000328:Adult; D016022:Case-Control Studies; D015986:Confounding Factors, Epidemiologic; D015658:HIV Infections / Q000150:complications / Q000453:epidemiology*; D006801:Humans; D008297:Male; D009092:Mucous Membrane; D016017:Odds Ratio; D011159:Population Surveillance; D015995:Prevalence; D012307:Risk Factors; D012747:Sexual Partners; D012871:Skin Diseases / Q000150:complications / Q000453:epidemiology*; D019966:Substance-Related Disorders / Q000150:complications*